SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001493152-21-016658
Filing Date
2021-07-12
Accepted
2021-07-12 17:15:00
Documents
1
Period of Report
2021-07-12

Document Format Files

Seq Description Document Type Size
1 ownership.html 3  
1 ownership.xml 3 3586
  Complete submission text file 0001493152-21-016658.txt   4925
Mailing Address C/O KADMON HOLDINGS, LLC 450 E. 29TH STREET NEW YORK NY 10016
Business Address
Ryan John L (Reporting) CIK: 0001679825 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-40582 | Film No.: 211086171

Mailing Address 5150 EL CAMINO REAL, SUITE A-32 LOS ALTOS CA 94022
Business Address 5150 EL CAMINO REAL, SUITE A-32 LOS ALTOS CA 94022 650-384-0642
Unicycive Therapeutics, Inc. (Issuer) CIK: 0001766140 (see all company filings)

IRS No.: 813638692 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations